Biocure Technology Inc. CUREX
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.50K | 29.70K | 30.20K | 35.70K | 39.20K |
| Total Receivables | 20.10K | -- | 2.00K | 1.20K | 5.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 600.00 | -- | 900.00 | 400.00 | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.20K | -- | 33.20K | 37.30K | 44.90K |
|
|
|||||
| Total Current Assets | 23.20K | -- | 33.20K | 37.30K | 44.90K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 23.20K | -- | 1.47M | 1.45M | 1.49M |
|
|
|||||
| Total Accounts Payable | 423.60K | -- | 254.40K | 238.30K | 392.10K |
| Total Accrued Expenses | 9.70K | -- | 20.10K | 17.90K | 18.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.00K | -- | 42.80K | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 478.30K | -- | 317.30K | 256.20K | 410.40K |
|
|
|||||
| Total Current Liabilities | 478.30K | -- | 317.30K | 256.20K | 410.40K |
| Long-Term Debt | -- | -- | -- | 40.40K | 39.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 478.30K | -- | 317.30K | 296.60K | 450.00K |
|
|
|||||
| Common Stock & APIC | 12.69M | -- | 13.14M | 12.93M | 13.03M |
| Retained Earnings | -18.42M | -- | -17.46M | -17.16M | -17.50M |
| Treasury Stock & Other | 5.28M | -- | 5.47M | 5.38M | 5.50M |
| Total Common Equity | -455.10K | 1.13M | 1.15M | 1.15M | 1.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -455.10K | 1.13M | 1.15M | 1.15M | 1.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -455.10K | 1.13M | 1.15M | 1.15M | 1.04M |
|
|
|||||